Based on the medical literature, let me explain why PT, aPTT, and Hb are altered in DVT patients.
Why PT and aPTT Are ELEVATED (Not Decreased)
I want to clarify an important point: PT and aPTT are typically PROLONGED (elevated/increased) in DVT patients, not decreased. Here's why:
1. Anticoagulation Therapy (Primary Reason)
Most DVT patients receive anticoagulant medications. The patient in your case is likely on one of these:
- Warfarin - blocks vitamin K-dependent factors (II, VII, IX, X), which prolongs PT and aPTT
- Heparin or Low-Molecular-Weight Heparin (LMWH) - enhances antithrombin activity, which prolongs aPTT
- Direct Xa inhibitors (rivaroxaban, apixaban, edoxaban)
According to Henry's Clinical Diagnosis textbook, "The degree of anticoagulation with warfarin is typically assessed by measuring prothrombin time (PT), although activated partial thromboplastin time (APTT) is also typically prolonged."
This prolongation is INTENTIONAL and THERAPEUTIC - it's the goal of treatment to thin the blood and prevent clot growth.
2. Underlying Hypercoagulable State (Why DVT Developed)
Before treatment, the coagulation cascade becomes OVERACTIVE in DVT. Robbins & Kumar Pathology explains this through Virchow's Triad:
- Endothelial injury - vessel wall damage activates procoagulants (tissue factor)
- Blood stasis - slow flow allows clotting factors to accumulate locally
- Hypercoagulability - increased procoagulant activity shifts the balance toward clot formation
When clotting factors are actively being consumed to form the thrombus, this is called consumption coagulopathy. However, this is usually mild in uncomplicated DVT and gets corrected by anticoagulation therapy.
Why Hemoglobin (Hb) Is DECREASED
Your patient's Hb is 13.1 (low; normal is 14-18). This can happen in DVT for several reasons:
1. Blood Loss
- If DVT was caused by trauma, bleeding, or surgical procedure
- Ongoing bleeding from the damaged vein or associated vessels
2. Hemodilution
- IV fluid administration during hospitalization dilutes blood, lowering Hb concentration
3. Chronic Disease/Inflammation
- Severe infection or systemic inflammation from DVT/PE can trigger anemia of chronic disease
- The thrombus and associated inflammation stimulate cytokines that suppress erythropoiesis
4. Underlying Conditions
- Cancer (cancer-associated thrombosis often includes anemia)
- Malabsorption of iron or B12
- Chronic renal disease (reduced erythropoietin production)
5. Medication Effects
- Some anticoagulants may increase bleeding risk, leading to occult blood loss
Summary Table
| Lab Value | Status | Why |
|---|
| PT (15.7) | Prolonged | Warfarin or heparin therapy (therapeutic goal) |
| aPTT (39.1) | Prolonged | Heparin therapy or warfarin (therapeutic goal) |
| Hb (13.1) | Decreased | Blood loss, hemodilution, inflammation, or chronic disease |
Bottom line: The elevated PT/aPTT are expected and desired in DVT treatment. The low Hb needs investigation into its cause - ask the doctor whether it's related to bleeding, fluid overload, or an underlying condition.